Literature DB >> 3040060

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.

P R Twentyman, N E Fox, D J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3040060      PMCID： PMC2001675          DOI： 10.1038/bjc.1987.153

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Chemistry of the natural cyclosporin metabolites.

Authors:  A von Wartburg; R Traber
Journal:  Prog Allergy       Date:  1986

2.  Enhancement of etoposide-induced cytotoxicity by cyclosporin A.

Authors:  R Osieka; S Seeber; R Pannenbäcker; D Soll; P Glatte; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Reversal of adriamycin resistance by verapamil in human ovarian cancer.

Authors:  A M Rogan; T C Hamilton; R C Young; R W Klecker; R F Ozols
Journal:  Science       Date:  1984-06-01       Impact factor: 47.728

4.  Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma.

Authors:  L M Slater; S L Murray; M W Wetzel; R M Wisdom; E M DuVall
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

5.  Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

6.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

7.  Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.

Authors:  L M Slater; P Sweet; M Stupecky; S Gupta
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

9.  Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

Authors:  P R Twentyman; N E Fox; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

10.  Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.

Authors:  L M Slater; P Sweet; M Stupecky; M W Wetzel; S Gupta
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640
View more
  40 in total

Review 1.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport.

Authors:  Shoji Yamaguchi; Ying Lan Zhao; Masayuki Nadai; Hideo Yoshizumi; Xiaobo Cen; Shoko Torita; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A.

Authors:  P R Twentyman; K A Wright
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

Review 5.  Roles of sildenafil in enhancing drug sensitivity in cancer.

Authors:  Zhi Shi; Amit K Tiwari; Atish S Patel; Li-Wu Fu; Zhe-Sheng Chen
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

Review 6.  Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications.

Authors:  A Gescher; U Pastorino; S M Plummer; M M Manson
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

7.  Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.

Authors:  K Häussermann; B Benz; V Gekeler; K Schumacher; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

9.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 10.  Malignancy in kidney transplant recipients.

Authors:  Anil Kapoor
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.